Search results
Showing 646 to 660 of 2580 results for methods
Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173)
This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.
Abortion care. Patient decision aid on choosing between medical or surgical abortion before 14 weeks
Most women have some bleeding and cramping for several days after either method, but these usually get better day by day. Having an...
In development Reference number: GID-TA11115 Expected publication date: TBC
Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly [ID1596]
In development Reference number: GID-TA10497 Expected publication date: TBC
In development Reference number: GID-TA11544 Expected publication date: 14 May 2026
Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]
In development Reference number: GID-TA11561 Expected publication date: 11 March 2026
NICE has developed a medtech innovation briefing (MIB) on the Epidrum for aiding access to the epidural space
This indicator covers the percentage of patients with diabetes who have a record of an albumin creatinine ratio (ACR) test in the preceding 15 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
In development Reference number: GID-TA11246 Expected publication date: 05 March 2026
In development Reference number: GID-TA11402 Expected publication date: TBC
Awaiting development Reference number: GID-TA11222 Expected publication date: TBC
What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...
NICE's partners
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]
Awaiting development Reference number: GID-TA11565 Expected publication date: 21 May 2026
In development Reference number: GID-TA11576 Expected publication date: 18 June 2026